Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases
Published in Antioxidants on August 12, 2022
Biostatistics research professor Dr. Lili Zhao reviews clinical trials of small molecule compounds that target nuclear factor erythoid 2-related factor 2 (Nrf2) for the treatment of inflammation-related diseases. Learn more here.